Extraordinary Evolutions in Electrophysiology (EP)
Advancements in medicine have enabled electrophysiologists to diagnose and treat heart rhythm abnormalities like never before. From the first pacemaker to the latest cardiac technology, follow us through the years and see what these innovations have made possible for you—and your patients.
1957
In the middle of a decade that already provided a series
of technological breakthroughs, another “first” included THE FIRST MYOCARDIAL WIRE
IMPLANT.
1957
In the middle of a decade that already provided a series
of technological breakthroughs, another “first” included THE FIRST MYOCARDIAL WIRE
IMPLANT.
1958 Building upon earlier successes, the wearable pacemaker gets a major upgrade as the first fully implantable pacemaker makes its debut.
1958 Building upon earlier successes, the wearable pacemaker gets a major upgrade as the first fully implantable pacemaker makes its debut.
1972
THE 1ST LITHIUM-
POWERED PACEMAKER. is implanted, providing greater reliability and improving countless patients' lives for years to come.
1980 While clinical experience with automatic
internal defibrillation is now widespread—used in treating over 65,000 patients—the first implantation occurred in 1980 at Johns Hopkins.
1980 While clinical experience with automatic
internal defibrillation is now widespread—used in treating over 65,000 patients—the first implantation occurred in 1980 at Johns Hopkins.
1985 With the ability to monitor cardiac rhythm and recognize
potentially life-threatening arrhythmias, THE AICD is granted approval for
general use by the Food and Drug
Administration (FDA).
1985 With the ability to monitor cardiac rhythm and recognize
potentially life-threatening arrhythmias, THE AICD is granted approval for
general use by the Food and Drug
Administration (FDA).
1993
Long-term reliability and failure rates are an
ongoing challenge, so it was an important milestone ENDOTAK - THE FIRST
TRANSVENOUS ENDOCARDIAL
DEFRIBILLATING LEAD - GETS FDA
APPROVAL.
1995
GUIDANT FIRST PECTORAL
PLACEMENT BIPHASIC IMPLANTABLE
CARDIO-DEFIBRILLATOR (ICD) is approved, along with the MINI and MDT Jewel providing
thinner, lighter options.
1996 The MADIT TRIAL (Multicenter Automatic Defibrillator Trial) studied the long-term benefit of SCD prevention by using an implantable cardioverter-defibrillator—which ultimately improved survival in a high-risk group.
1996 The MADIT TRIAL (Multicenter Automatic Defibrillator Trial) studied the long-term benefit of SCD prevention by using an implantable cardioverter-defibrillator—which ultimately improved survival in a high-risk group.
1997
Another "first"— an advancement that helped correct life threatening heart rhythm disorders. The VENTAK AV, the first dual-chamber ICD, is approved by the FDA and hits the U.S. market.
2002
THE RESULTS FROM THE MADIT II (MULTICENTER AUTOMATIC DEFIBRILLATOR TRIAL) prompted a new indication for AICDs. Patients with a history of an MI and are identified as being at risk of SCD are now indicated for a device implanted before suffering their first SCD.
THE CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P) IS FDA APPROVED Delivering small electrical impulses, it ensures the left and right ventricles contract at the same time, helping the heart pump more efficiently.
2005 Sudden cardiac death (SCD) is the leading cause of death in the United States. The SCD-HeFT trial helped demonstrate that ICDs reduced mortality for high-risk patients, compared to conventional therapy.
2005 Sudden cardiac death (SCD) is the leading cause of death in the United States. The SCD-HeFT trial helped demonstrate that ICDs reduced mortality for high-risk patients, compared to conventional therapy.
2012
THE FDA GRANTS APPROVAL FOR OUR S-ICD® SYSTEM the world's first commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
2012 THE NANOSTIM™ PACEMAKER
IS FIRST IMPLANTED. Designed to be placed directly in the heart, it's a non-surgical solution without the visible scar and leads required in conventional pacemakers.
2012 THE NANOSTIM™ PACEMAKER
IS FIRST IMPLANTED. Designed to be placed directly in the heart, it's a non-surgical solution without the visible scar and leads required in conventional pacemakers.
2015 Communication between a subcutaneous implantable cardioverter-defibrillator (S-ICD) and a leadless pacemaker (LP) is demonstrated in preclinical models, proving the feasibility of the LP design and modular system.
2015 Communication between a subcutaneous implantable cardioverter-defibrillator (S-ICD) and a leadless pacemaker (LP) is demonstrated in preclinical models, proving the feasibility of the LP design and modular system.
